MicroPort CardioFlow Medtech 관리
관리 기준 확인 2/4
We currently do not have sufficient information about the CEO.
주요 정보
Jeffrey R Lindstrom
최고 경영자
CN¥4.0m
총 보상
| CEO 급여 비율 | 59.8% |
| CEO 임기 | 1.3yrs |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | 4.1yrs |
| 이사회 평균 재임 기간 | 3.8yrs |
최근 관리 업데이트
Recent updates
MicroPort CardioFlow Medtech Corporation (HKG:2160) Stocks Shoot Up 34% But Its P/S Still Looks Reasonable
Sep 27
After Leaping 34% MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares Are Not Flying Under The Radar
Sep 27Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?
Aug 07Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding
Jun 19MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
May 29MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely
Apr 05We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Feb 23An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued
Jan 18Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth
Oct 04Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%
May 31We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
May 23The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts
Apr 06MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
Feb 08We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Oct 18We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate
Jun 30Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts
Apr 04MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Apr 03An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued
Jan 21Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?
Sep 05We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn
Jun 07Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)
May 03CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥349m |
| Mar 31 2024 | n/a | n/a | -CN¥410m |
| Dec 31 2023 | CN¥4m | CN¥2m | -CN¥472m |
보상 대 시장: Jeffrey R's total compensation ($USD564.57K) is above average for companies of similar size in the Hong Kong market ($USD359.95K).
보상과 수익: Insufficient data to compare Jeffrey R's compensation with company performance.
CEO
Jeffrey R Lindstrom (57 yo)
1.3yrs
테뉴어
CN¥4,004,000
보상
Mr. Jeffrey R Lindstrom is President, Executive Director & General Manager of MicroPort CardioFlow Medtech Corporation from August 29, 2023. He served as senior director of engineering in Edwards Lifescien...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 1.3yrs | CN¥4.00m | 데이터 없음 | |
| Executive Director & First VP of Total Solutions | 2.5yrs | CN¥3.91m | 0.058% HK$ 1.0m | |
| VP & Executive Director | 4.2yrs | CN¥2.70m | 0.042% HK$ 718.8k | |
| Joint Company Secretary | 4.1yrs | 데이터 없음 | 데이터 없음 | |
| Joint Company Secretary | 4.1yrs | 데이터 없음 | 데이터 없음 |
4.1yrs
평균 재임 기간
43yo
평균 연령
경험이 풍부한 관리: 2160's management team is considered experienced (4.1 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 1.3yrs | CN¥4.00m | 데이터 없음 | |
| Executive Director & First VP of Total Solutions | 2.5yrs | CN¥3.91m | 0.058% HK$ 1.0m | |
| VP & Executive Director | 4.2yrs | CN¥2.70m | 0.042% HK$ 718.8k | |
| Independent Non-Executive Director | 3.8yrs | CN¥254.00k | 데이터 없음 | |
| Non-Executive Director | 5.3yrs | 데이터 없음 | 데이터 없음 | |
| Non-Executive Chairman of the Board | 4.2yrs | CN¥3.16m | 0.031% HK$ 527.4k | |
| Non-Executive Director | 5.3yrs | 데이터 없음 | 데이터 없음 | |
| Independent Non-Executive Director | 3.8yrs | CN¥254.00k | 데이터 없음 | |
| Independent Non-Executive Director | 3.3yrs | CN¥254.00k | 0.0012% HK$ 21.2k |
3.8yrs
평균 재임 기간
47yo
평균 연령
경험이 풍부한 이사회: 2160's board of directors are considered experienced (3.8 years average tenure).